{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:29:13Z","timestamp":1793964553844,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":85,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.100931","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:47:15Z","timestamp":1776239235000},"page":"100931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Anticholinergic burden in fibromyalgia treatment analysis: Guidelines adherence and pharmacological alerts"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4659-6159","authenticated-orcid":false,"given":"Teresa","family":"Lopez de Coca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5914-0516","authenticated-orcid":false,"given":"Mar\u00eda","family":"Sebastian-Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-5398","authenticated-orcid":false,"given":"Roxana","family":"Gonz\u00e1lez-Mazar\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9456-9649","authenticated-orcid":false,"given":"Lucrecia","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clinsp.2026.100931_bib0001","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1525-1497.2000.06279.x","article-title":"Treatment of fibromyalgia with antidepressants: a meta-analysis","volume":"15","author":"O\u2019Malley","year":"2000","journal-title":"J Gen Intern Med"},{"issue":"9","key":"10.1016\/j.clinsp.2026.100931_bib0002","article-title":"Is fibromyalgia a fashionable diagnosis or a medical mystery?","volume":"15","author":"Varrassi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.clinsp.2026.100931_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.747533","article-title":"Working memory performance, pain and associated clinical variables in women with fibromyalgia","volume":"12","author":"Gil-Ugidos","year":"2021","journal-title":"Front Psychol"},{"key":"10.1016\/j.clinsp.2026.100931_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.848009","article-title":"Characterizing neurocognitive impairment in juvenile fibromyalgia syndrome: subjective and objective measures of dyscognition","volume":"10","author":"Gmuca","year":"2022","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.clinsp.2026.100931_bib0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4081\/reumatismo.2012.206","article-title":"Fibromyalgia dyscognition: concepts and issues","volume":"64","author":"Ambrose","year":"2012","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100931_bib0006","doi-asserted-by":"crossref","DOI":"10.1080\/24740527.2023.2217865","article-title":"Understanding the experience and impacts of brain fog in chronic pain: a scoping review","volume":"7","author":"Dass","year":"2023","journal-title":"Can J Pain"},{"issue":"4","key":"10.1016\/j.clinsp.2026.100931_bib0007","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/acr2.11130","article-title":"The role of environmental distractions in the experience of fibrofog in real-world settings","volume":"2","author":"Kratz","year":"2020","journal-title":"ACR Open Rheumatol"},{"issue":"12","key":"10.1016\/j.clinsp.2026.100931_bib0008","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/acr.24089","article-title":"Fibrofog in daily life: an examination of ambulatory subjective and objective cognitive function in fibromyalgia","volume":"72","author":"Kratz","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.clinsp.2026.100931_bib0009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/0115733971274700231226075717","article-title":"Diet and lifestyle modifications for fibromyalgia","volume":"20","author":"Metyas","year":"2024","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100931_bib0010","doi-asserted-by":"crossref","first-page":"e4771","DOI":"10.1002\/ejp.4771","article-title":"Pain sensitization in fibromyalgia. Cross-sectional associations between quantitative sensory testing of pain sensitization and fibromyalgia disease burden","volume":"29","author":"Pettersen","year":"2025","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clinsp.2026.100931_bib0011","unstructured":"Who.int. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/39524\/WHO_TRS_804.pdf."},{"issue":"9","key":"10.1016\/j.clinsp.2026.100931_bib0012","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14656566.2015.1047343","article-title":"An update on pharmacotherapy for the treatment of fibromyalgia","volume":"16","author":"Calandre","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"10289","key":"10.1016\/j.clinsp.2026.100931_bib0013","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100931_bib0014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/jpm12020207","article-title":"CRIDECO anticholinergic load scale: an updated anticholinergic burden scale. Comparison with the ACB scale in Spanish individuals with subjective memory complaints","volume":"12","author":"Ramos","year":"2022","journal-title":"J Pers Med"},{"issue":"9","key":"10.1016\/j.clinsp.2026.100931_bib0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/phar.2612","article-title":"Risk of fall-related injury and all-cause hospitalization of select concomitant central nervous system medication prescribing in older adult persistent opioid users: a case-time-control analysis","volume":"41","author":"Moran","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinsp.2026.100931_bib0016","series-title":"La FDA Exige Un Recuadro de Advertencia Actualizado Para Mejorar El Uso Seguro De Los Medicamentos De La Clase De Las Benzodiazepinas","year":"2020"},{"issue":"989","key":"10.1016\/j.clinsp.2026.100931_bib0017","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/pgmj.2007.062117","article-title":"Neuropsychiatric complications of commonly used palliative care drugs","volume":"84","author":"Jackson","year":"2008","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100931_bib0018","doi-asserted-by":"crossref","first-page":"803Y815","DOI":"10.1007\/s00414-010-0536-3","article-title":"Deaths involving contraindicated and inappropriate combinations of serotonergic drugs","volume":"125","author":"Pilgrim","year":"2011","journal-title":"Int J Legal Med"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100931_bib0019","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4037\/ccn2017169","article-title":"Drug-induced serotonin syndrome","volume":"37","author":"Bartlett","year":"2017","journal-title":"Crit Care Nurse"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100931_bib0020","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","article-title":"Chronic pain: a review of its epidemiology and associated factors in population-based studies","volume":"123","author":"Mills","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clinsp.2026.100931_bib0021","series-title":"ATC Classification Index With DDDs, 2022","year":"2021"},{"key":"10.1016\/j.clinsp.2026.100931_bib0022","unstructured":"CheckTheMeds Technology SL. CheckTheMeds. Inicio. Checkthemeds.com. Available from: https:\/\/www.checkthemeds.com."},{"key":"10.1016\/j.clinsp.2026.100931_bib0023","unstructured":"Ser.es. Available from: https:\/\/www.ser.es\/wp-content\/uploads\/2020\/11\/Recomendaciones_SER_FM_DEF.pdf."},{"issue":"2","key":"10.1016\/j.clinsp.2026.100931_bib0024","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.clinsp.2026.100931_bib0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"Declaraci\u00f3n PRISMA 2020: una gu\u00eda actualizada para la publicaci\u00f3n de revisiones sistem\u00e1ticas","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol"},{"issue":"5","key":"10.1016\/j.clinsp.2026.100931_bib0026","doi-asserted-by":"crossref","first-page":"ITC33","DOI":"10.7326\/AITC202003030","article-title":"Fibromyalgia","volume":"172","author":"Bair","year":"2020","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.1016\/j.clinsp.2026.100931_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191912106","article-title":"Review of fibromyalgia (FM) syndrome treatments","volume":"19","author":"Cohen-Biton","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100931_bib0028","first-page":"1205","article-title":"Fibromyalgia: one year in review 2023","volume":"41","author":"Giorgi","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.clinsp.2026.100931_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.semerg.2023.102177","article-title":"El consumo de medicamentos como factor asociado al estado de fragilidad en personas mayores de 65 a\u00f1os en Espa\u00f1a","volume":"50","author":"Ignacio Exp\u00f3sito","year":"2024","journal-title":"Semergen"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100931_bib0030","doi-asserted-by":"crossref","first-page":"8726","DOI":"10.1038\/s41598-024-58030-w","article-title":"Exploring the association between dietary Inflammatory Index and chronic pain in US adults using NHANES 1999-2004","volume":"14","author":"Qing","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.clinsp.2026.100931_bib0031","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jpain.2022.03.237","article-title":"Dietary Inflammatory Index (DII) is associated with movement-evoked pain severity in adults with chronic low back pain: sociodemographic differences","volume":"23","author":"Strath","year":"2022","journal-title":"J Pain"},{"issue":"7","key":"10.1016\/j.clinsp.2026.100931_bib0032","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/ejp.1207","article-title":"Effects of a Standard American Diet and an anti-inflammatory diet in male and female mice","volume":"22","author":"Totsch","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clinsp.2026.100931_bib0033","article-title":"Systematic review: exploring the impact of nutrition on acute pain including cancer pain","author":"Parthasarathy","year":"2024","journal-title":"Oncologyradiotherapy.com"},{"issue":"21","key":"10.1016\/j.clinsp.2026.100931_bib0034","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.3390\/jcm10215203","article-title":"Diet and chronic non-cancer pain: the state of the art and future directions","volume":"10","author":"Brain","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100931_bib0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40122-020-00200-5","article-title":"Dietary interventions for treatment of chronic pain: oxidative stress and inflammation","volume":"9","author":"Kaushik","year":"2020","journal-title":"Pain Ther"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100931_bib0036","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40122-021-00239-y","article-title":"Food for Special medical purposes and nutraceuticals for pain: a narrative review","volume":"10","author":"Casale","year":"2021","journal-title":"Pain Ther"},{"issue":"5","key":"10.1016\/j.clinsp.2026.100931_bib0037","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s40122-024-00641-2","article-title":"Neuronutritional approach to fibromyalgia management: a narrative review","volume":"13","author":"Badaeva","year":"2024","journal-title":"Pain Ther"},{"key":"10.1016\/j.clinsp.2026.100931_bib0038","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2018.04.056","article-title":"Fibromyalgia and nutrition: therapeutic possibilities?","volume":"103","author":"Bj\u00f8rklund","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100931_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/msc.70057","article-title":"Differences in ferritin, vitamin D, and vitamin B12 between fibromyalgia patients and healthy individuals: a systematic review and meta-analysis","volume":"23","author":"Ismail","year":"2025","journal-title":"Musculoskeletal Care"},{"key":"10.1016\/j.clinsp.2026.100931_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/DMSO.S187268","article-title":"Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes","volume":"12","author":"Dur\u00e1n","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"10.1016\/j.clinsp.2026.100931_bib0041","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3390\/nu12092664","article-title":"Dietary interventions in the management of fibromyalgia: a systematic review and best-evidence synthesis","volume":"12","author":"Lowry","year":"2020","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.clinsp.2026.100931_bib0042","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.3390\/ijerph19074148","article-title":"Bioactive compounds for fibromyalgia-like symptoms: a narrative review and future perspectives","volume":"19","author":"Shen","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100931_bib0043","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12969-021-00529-x","article-title":"Juvenile primary fibromyalgia syndrome: a review- treatment and prognosis","volume":"19","author":"Coles","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100931_bib0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/ph17020205","article-title":"Risk factors for respiratory depression associated with tramadol based on the global pharmacovigilance database (VigiBase)","volume":"17","author":"Park","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100931_bib0046","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40266-024-01116-x","article-title":"Associations between midlife anticholinergic medication use and subsequent cognitive decline: a British birth cohort study","volume":"41","author":"Rawle","year":"2024","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100931_bib0047","doi-asserted-by":"crossref","first-page":"240","DOI":"10.21037\/apm-23-537","article-title":"Prevalence and characteristics of patients prescribed opioids and central nervous system depression agents on discharge to hospice care","volume":"13","author":"Nguyen","year":"2024","journal-title":"Ann Palliat Med"},{"issue":"5","key":"10.1016\/j.clinsp.2026.100931_bib0048","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1021\/acschemneuro.6b00412","article-title":"Immune system activation and depression: roles of serotonin in the central nervous system and periphery","volume":"8","author":"Robson","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.clinsp.2026.100931_bib0049","unstructured":"Aemps.es. Available online: https:\/\/cima.aemps.es\/cima\/pdfs\/es\/ft\/63734\/63734_ft.pdf."},{"issue":"11","key":"10.1016\/j.clinsp.2026.100931_bib0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5414\/CP203798","article-title":"Polypharmacy in three different spontaneous adverse drug event databases","volume":"58","author":"Mabuchi","year":"2020","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.clinsp.2026.100931_bib0051","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.3390\/nu16111620","article-title":"Investigating the effectiveness of a carb-free oloproteic diet in fibromyalgia treatment","volume":"16","author":"Castaldo","year":"2024","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.clinsp.2026.100931_bib0052","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.apmr.2017.02.011","article-title":"Effects of exergames on quality of life, pain, and disease effect in women with fibromyalgia: a randomized controlled trial","volume":"98","author":"Collado-Mateo","year":"2017","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226000724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226000724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:17:09Z","timestamp":1793963829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593226000724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"alternative-id":["S1807593226000724"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.100931","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticholinergic burden in fibromyalgia treatment analysis: Guidelines adherence and pharmacological alerts","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.100931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100931"}}